Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine
Grant Award Details
Grant Type:
Grant Number:
EDUC4-12756
Investigator(s):
Award Value:
$5,373,742
Status:
Active
Progress Reports
Reporting Period:
Year 1
Reporting Period:
Year 2
Reporting Period:
Year 3
Grant Application Details
Application Title:
Training Program Bridging Stem Cell Research with Clinical Applications in Regenerative Medicine
Public Abstract:
This is a proposal to train the next generation of stem cell researchers at the predoctoral, postdoctoral, and clinical levels. A major emphasis of the training program is to bridge cutting-edge research in stem cell biology with its clinical potential in regenerative medicine. The host institution is uniquely qualified to offer this training program as it has undergone dramatic growth in stem cell research in the last decade. The institution has launched a new Department of Stem Cell Biology and Regenerative Medicine, opened a dedicated stem cell building financed by private donations and a CIRM Major Facilities Award, and created dedicated PhD and master’s programs in stem cells and regenerative medicine. Key features of this program are an intensive course in stem cell biology and regenerative medicine, a course in ethics and regulatory guidelines, a discussion course led by practicing clinicians, and a hands-on workshop in cell and gene therapy manufacturing. The program includes an overnight retreat involving diverse stem cell researchers across multiple schools, career and professional development workshops, and numerous opportunities for interactions with patient advocates and the local community. A unique aspect is the direct involvement of clinicians in all aspects of the training program. Each trainee is required to have a clinical co-mentor, who will guide them in understanding the clinical potential of their research. The program has 60 training faculty in fields ranging from basic stem cell research to bioengineering, computational biology, immunology, and clinical research, providing trainees with a wide range of choices of mentors. The proposed program will train 3 predoctoral, 5 postdoctoral, and 3 clinical fellows, with private donations bringing the number of clinical fellows to 6 per year. This investment in training clinical fellows reflects the goal of the training program to bridge stem cell research with its clinical potential. Trainees will be supported for 2–3 years, and will be expected to perform rigorous research, complete both didactic and hands-on coursework, attend and present their work at weekly stem cell research presentations and an annual retreat, regularly engage with clinicians and patient advocates, and mentor local high school students and undergrads, many of whom come from groups underrepresented in STEM fields. The host institution has a long track record of successful training, including two previous CIRM Training Programs that produced researchers who are now professors at MIT, Columbia, UCLA, UC Irvine, etc., as well as leaders in stem cell-focused biotech companies in California. The formalized mentoring and career guidance available will ensure that the program continues to produce the world-class researchers who will bring future cell and gene therapies to patients suffering from currently incurable diseases.
Statement of Benefit to California:
Millions of Californians suffer from incurable diseases, ranging from arthritis to debilitating neurodegenerative diseases. The promise of stem cell research to identify cures for many of these diseases has never been greater, but significant progress requires an influx of new, talented researchers and clinicians. This program is focused on rigorous training of the next generation of stem cell researchers and clinician-scientists, who will develop and implement the cures of the future. These trainees will become the research faculty who push stem cell research forward at major California universities, as well as the entrepreneurs who start new companies to produce cell and gene therapies for patients. These trainees will continue the enormous growth of stem cell science and regenerative medicine in California, generating billions of dollars of tax revenue and bettering the lives of patients looking for new types of treatments for debilitating disease. The track record of the host institution in trainee development, as well as its well-developed research and academic programs, make it highly qualified to run the proposed training program. The novel focus of the training program in bringing basic researchers and clinicians together reflects the mission of this next phase of CIRM to translate cutting-edge stem cell research into patient therapies.
Publications
- Cell Mol Immunol (2024): Age-associated imbalance in immune cell regeneration varies across individuals and arises from a distinct subset of stem cells. (PubMed: 39443746)
- Nat Neurosci (2022): Altered adult neurogenesis and gliogenesis in patients with mesial temporal lobe epilepsy. (PubMed: 35383330)
- Cell (2021): Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis. (PubMed: 33417861)
- Development (2023): Craniofacial developmental biology in the single-cell era. (PubMed: 37812056)
- Nat Commun (2021): Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses. (PubMed: 34764253)
- Nat Commun (2021): The developing mouse coronal suture at single-cell resolution. (PubMed: 34376651)
- Dev Cell (2022): EED is required for mouse primordial germ cell differentiation in the embryonic gonad. (PubMed: 35679863)
- Nat Commun (2024): Engineering programmable material-to-cell pathways via synthetic notch receptors to spatially control differentiation in multicellular constructs. (PubMed: 39003263)
- Elife (2021): Foxc1 establishes enhancer accessibility for craniofacial cartilage differentiation. (PubMed: 33501917)
- Sci Adv (2024): Label-free metabolic optical biomarkers track stem cell fate transition in real time. (PubMed: 38718114)
- Nat Commun (2022): Lifelong single-cell profiling of cranial neural crest diversification in zebrafish. (PubMed: 35013168)
- NPJ Regen Med (2023): Ligament injury in adult zebrafish triggers ECM remodeling and cell dedifferentiation for scar-free regeneration. (PubMed: 37726321)
- NPJ Regen Med (2021): Long-term repair of porcine articular cartilage using cryopreservable, clinically compatible human embryonic stem cell-derived chondrocytes. (PubMed: 34815400)
- Nat Cell Biol (2022): Not all cortical organoids are created equal. (PubMed: 35697780)
- Nature (2023): Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer. (PubMed: 36991126)
- Circ Res (2022): Piezo1-Regulated Mechanotransduction Controls Flow-Activated Lymphatic Expansion. (PubMed: 35701867)
- Nat Neurosci (2024): Piezo1 regulates meningeal lymphatic vessel drainage and alleviates excessive CSF accumulation. (PubMed: 38528202)
- Biol Psychiatry (2023): Present and Future Modeling of Human Psychiatric Connectopathies With Brain Organoids. (PubMed: 36759258)
- STAR Protoc (2023): Protocol for the isolation of mouse muscle stem cells using fluorescence-activated cell sorting. (PubMed: 37874680)
- Front Cell Dev Biol (2021): Regeneration of Jaw Joint Cartilage in Adult Zebrafish. (PubMed: 35127702)
- J Surg Res (2024): Resuscitative Thoracotomy for Traumatic Cardiac Arrest: Potential Impact of Resource Constraint on Outcomes and Blood Product Utilization. (PubMed: 38128347)
- Hum Mol Genet (2023): Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD/ALS neurodegeneration and behaviors. (PubMed: 36322143)
- EMBO Rep (2021): Reversing neural circuit and behavior deficit in mice exposed to maternal inflammation by Zika virus. (PubMed: 34232545)
- Blood (2023): RNA splicing factor Rbm25 underlies heterogeneous preleukemic clonal expansion in mice. (PubMed: 36947858)
- Nat Commun (2023): Sensory nerve niche regulates mesenchymal stem cell homeostasis via FGF/mTOR/autophagy axis. (PubMed: 36670126)
- Am Surg (2022): Telemedicine Experience of General Surgery Trainees: Impact on Patient Care and Education. (PubMed: 34049446)
- Circ Res (2022): VE-Cadherin: A Critical Sticking Point for Lymphatic System Maintenance: Role of VE-Cadherin in Lymphatic Maintenance. (PubMed: 34995134)